Skip to main content

Table 2 A section of the dosage quotient table generated for an abnormal sample.

From: Detection of subtelomere imbalance using MLPA: validation, development of an analysis protocol, and application in a diagnostic centre

6p

7p

8p

9p

10p

11p

12p

13p

14p

15p

16p

0.99

0.99

0.97

0.95

1.06

0.49

1.03

1.03

1.05

0.99

2.00

1.03

0.99

0.94

1.03

0.97

0.51

1.05

1.02

1.02

2.00

0.98

1.03

0.97

1.02

0.95

1.01

0.52

1.05

1.00

2.04

0.99

1.01

1.00

1.04

0.94

0.99

1.03

0.52

1.02

1.99

1.00

1.01

0.98

1.08

0.96

0.98

1.00

1.03

0.50

2.03

0.98

1.03

0.99

1.00

1.04

1.02

0.99

0.97

1.99

0.49

1.02

0.97

1.01

1.00

1.04

1.06

1.01

0.97

1.94

0.98

0.50

1.00

0.99

1.02

1.02

0.99

1.05

0.99

1.92

0.95

1.00

0.49

1.01

0.99

1.06

0.98

0.99

1.02

1.97

0.95

0.98

0.97

0.50

1.02

1.03

1.01

0.99

1.00

2.04

0.97

0.97

0.95

1.00

0.50

1.05

0.98

1.01

1.00

0.97

6p

7p

8p

9p

10p

11p

12p

13p

14p

15p

16p

N

N

N

N

N

DEL

N

N

N

N

N

  1. The top and penultimate rows show the MLPA probe; each probe's 10 corresponding dosage quotients (generated from 10 flanking peaks) are shown in the column below. Abnormal ratios are highlighted in bold. The bottom row shows the result for each probe, where N signifies copy number of 2 and DEL signifies copy number of 1.